Effect of Clarithromycin and Rifampicin on the Pharmacokinetics of XZP-3287 in Healthy Subjects
Clinical trial NCT04951713 · UNKNOWN
Trial details
- NCT number
- NCT04951713
- Sponsor
- Xuanzhu Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2021-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.